InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,273.54
(
0.29%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DonShimoda

Send PM Follow Ignore
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

DonShimoda

Re: vidpok45 post# 15318

Monday, 12/19/2011 10:24:00 AM

Monday, December 19, 2011 10:24:00 AM

Post# of 80490
It's possible. It depends on 1) how quickly the phase 1 trial enrolls, 2) what the safety profile is, 3) whether the fda accepts a phase 2 registration trial and 4) if they do accept a pivotal P2, what the trial design is (eg sufficient crizotinib failures to power the trial). 2014 is much more likely, imo, which gives us all (well, some of us anyway) something to look forward to, lol.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up